Hemispherx Ampligen Filing Will Jumpstart NDA Clock
This article was originally published in The Pink Sheet Daily
Executive Summary
Biopharma accelerates evaluation of the Toll-like receptor-3 agonist as an adjuvant for HIV/AIDS and avian influenza vaccines.